Metraipolis › archive › dc_b172bb6d0bca
TLR4-Mediated Immune Dysfunction Links MASLD and Parkinson's Disease: Insights from an Omics-Based Network Analysis — Europe PMC PMID:41874031
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41874031
- DOI
- 10.3390/neurosci7020028
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T12:49:21.185Z
- SHA-256 of the archived text
dd5a45b8bb711d6ca2117cff89a3507090a071719ab3496d3548c5f5ed2df040- Stable URL of this page
https://metraipolis.com/documento/dc_b172bb6d0bca
How to cite
TLR4-Mediated Immune Dysfunction Links MASLD and Parkinson's Disease: Insights from an Omics-Based Network Analysis — Europe PMC PMID:41874031 — Europe PMC (en), https://europepmc.org/article/MED/41874031 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b172bb6d0bca (Metraipolis archive dc_b172bb6d0bca, sha256 dd5a45b8bb711d6ca2117cff89a3507090a071719ab3496d3548c5f5ed2df040)
BibTeX
@misc{dcb172bb6d0bca,
title = {TLR4-Mediated Immune Dysfunction Links MASLD and Parkinson's Disease: Insights from an Omics-Based Network Analysis — Europe PMC PMID:41874031},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41874031},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b172bb6d0bca; sha256 dd5a45b8bb711d6ca2117cff89a3507090a071719ab3496d3548c5f5ed2df040},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41874031. Agents can read the archived copy with the MCP tool read_document.